Public Engagement

See our upcoming events


Jenner Institute




BMA Award: Exploiting exosomes to improve vaccines for influenza & other infectious diseases

BMA Award: Exploiting exosomes to improve vaccines for influenza & other infectious diseases

Posted 25/11/2016

Jenner Institute scientists, Dr Lynda Coughlan and Prof Adrian Hill have been awarded the 2016 British Medical Association HC Roscoe grant for a research project which aims to develop improved vaccines for influenza. Fifteen medical academics and research scientists were awarded a total of ...

UK Zika research awarded share of £120 million vaccine fund

Posted 21/11/2016

UK researchers creating new vaccines for epidemic diseases such as Zika and Ebola are among the winners of £22 million of funding, announced by the Department of Health today. These projects will be the first to benefit from the UK Vaccine Network, a £120 million fund launched last year to support Britain’s world-leading role fighting deadly diseases. The network  brings together leading figures from industry, academia and philanthropy, including the Jenner Institute, University of Oxford, the Wellcome Trust, and GlaxoSmithKline (GSK).

News Archive

Recent Publications

The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8+ T Cells Present in the Liver. J Immunol. Article

Assessment of the Plasmodium falciparum pre-erythrocytic antigen UIS3 as a potential candidate for a malaria vaccine. Infect Immun. Article

Clinical Trials

Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.

If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.

Jenner Institute Podcasts

See all Jenner podcasts


Prof Gavin Screaton: Human antibody responses to dengue/Zika virus infections, 20/Jan/2017 12:00

Dr Michael Jarvis: Herpesvirus-based Vaccines for Infectious Disease & Cancer: An uncarved block, 23/Jan/2017 12:00

All Seminars